Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-01-06 @ 10:07 PM
Study NCT ID:
NCT05565092
Status:
TERMINATED
Last Update Posted:
2025-01-13
First Post:
2022-09-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-15
First Submit QC Date:
None
Study First Post Date:
2022-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-13
Results First Submit QC Date:
None
Results First Post Date:
2025-01-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-08
Last Update Post Date:
2025-01-13
Last Update Post Date Type:
ACTUAL